Johnson & Johnson: Resultados
Johnson & Johnson ha presentado resultados del primer trimestre dando un beneficio de 4,53 mil millones $, que en términos relativos es 1,62 $ por acción, que viene a ser casi un 30% de subida del beneficio de 3,51 mil millones $ del mismo trimestre del año pasado, que fue 1,26 $ por acción.
Los ingresos también han aumentado aunque no en la misma proporción, ascendiendo a 15,63 mil millones $ en el primer trimestre.
El mercado esperaba, según el consenso de analistas en torno a un beneficio de 1,27 $ por acción y unos ingresos de 15,61 mil millones $.
Para más información :
Johnson & Johnson Reports 2010 First-Quarter Results:
–Sales of $15.6 Billion Increased 4.0% Versus 2009 First Quarter; EPS was $1.62 –Excluding Special Items, 2010 First-Quarter EPS was $1.29, an increase of 2.4%*
NEW BRUNSWICK, N.J., April 20, 2010 /PRNewswire via COMTEX News Network/ — Johnson & Johnson (NYSE: JNJ) today announced sales of $15.6 billion for the first quarter of 2010, an increase of 4.0% as compared to the first quarter of 2009. Operational results declined 0.1% and the positive impact of currency was 4.1%. Domestic sales declined 5.0%, while international sales increased 14.4%, reflecting operational growth of 5.5% and a positive currency impact of 8.9%.
Net earnings and diluted earnings per share for the first quarter of 2010 were $4.5 billion and $1.62, respectively. First-quarter 2010 net earnings included an after-tax gain of $910 million representing the net impact of litigation matters. Excluding this special item, net earnings for the current quarter were $3.6 billion and diluted earnings per share were $1.29, representing increases of 3.1% and 2.4%, respectively, as compared to the same period in 2009.* The Company updated its earnings guidance for full-year 2010 to $4.80 – $4.90 per share to reflect recent changes in foreign currency exchange rates. Earnings guidance excludes the impact of special items and now incorporates the impact of recently enacted health care reform legislation.
sigue en: Johnson & Johnson Reports 2010 First-Quarter Results